Optibrium adds augmented intelligence for compound design to its StarDrop small molecule drug discovery software
New Inspyra module combines chemists’ expertise with exploratory capabilities of automated compound
New Inspyra module combines chemists’ expertise with exploratory capabilities of automated compound
The study demonstrates the accuracy and predictive capability of proprietary deep learning for developing flavours and fragrances, and in drug discovery
The innovative predictive methods support virtual screening and compound design in the absence of 3D structure data
Industry-leading 3D ligand-based design approaches from BioPharmics will be available in StarDrop, Optibrium’s small molecule design and optimization software
Investment by Kester Capital will drive commercial growth and the development of new products to improve speed, efficiency, and productivity of the discovery process
Incorporation of AI technologies highlights the most accurate compound predictions to enable effective project decision-making
New platform adds seamless link to compound structure assessment in 3D docking and alignment models
Seamless link between 2D and 3D structure-activity relationships guides more efficient compound optimization
Updated software expands capabilities for creative compound exploration and design on the iPad®